These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16423201)

  • 21. Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase.
    Xu D; Zhang Z; Jin L; Chu F; Mao Y; Wang H; Liu M; Wang M; Zhang L; Gao GF; Wang FS
    Eur J Clin Microbiol Infect Dis; 2005 Mar; 24(3):165-71. PubMed ID: 15789222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A serological survey on neutralizing antibody titer of SARS convalescent sera.
    Zhang JS; Chen JT; Liu YX; Zhang ZS; Gao H; Liu Y; Wang X; Ning Y; Liu YF; Gao Q; Xu JG; Qin C; Dong XP; Yin WD
    J Med Virol; 2005 Oct; 77(2):147-50. PubMed ID: 16121363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Serum antibodies detection for serological diagnosis of severe acute respiratory syndrome].
    National Research Project For SARS Beijing Group
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Jun; 26(6):339-42. PubMed ID: 12899765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibodies against human epithelial cells and endothelial cells after severe acute respiratory syndrome (SARS)-associated coronavirus infection.
    Yang YH; Huang YH; Chuang YH; Peng CM; Wang LC; Lin YT; Chiang BL
    J Med Virol; 2005 Sep; 77(1):1-7. PubMed ID: 16032747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison among four kits in detection of anti-SARS-CoV IgG in sera of SARS patients].
    Liu XE; Li J; Li YH; Wang L; Li T; Lu HY; Wang GF; Zhu WF; Gao XM; Wang YC; Zhao ZD; Xu XY; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):514-6. PubMed ID: 15231132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suggested new breakpoints of anti-MERS-CoV antibody ELISA titers: performance analysis of serologic tests.
    Ko JH; Müller MA; Seok H; Park GE; Lee JY; Cho SY; Ha YE; Baek JY; Kim SH; Kang JM; Kim YJ; Jo IJ; Chung CR; Hahn MJ; Drosten C; Kang CI; Chung DR; Song JH; Kang ES; Peck KR
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2179-2186. PubMed ID: 28695355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome.
    Lee N; Chan PK; Ip M; Wong E; Ho J; Ho C; Cockram CS; Hui DS
    J Clin Virol; 2006 Feb; 35(2):179-84. PubMed ID: 16112612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome.
    Liu W; Fontanet A; Zhang PH; Zhan L; Xin ZT; Baril L; Tang F; Lv H; Cao WC
    J Infect Dis; 2006 Mar; 193(6):792-5. PubMed ID: 16479513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The application of indirect immuno-fluorescence assay in the diagnosis of severe acute respiratory syndrome].
    Fang LQ; Zhang PH; Yang BA; Wu XM; Zhao QM; Liu W; Liu H; Deng YQ; Zhan L; Han WG; Lu FS; Wu JS; Yang H; Zhu QY; Cao WC
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jun; 24(6):484-6. PubMed ID: 12848915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dynamic changes of immunoglobulin G in convalescents who have suffered from severe acute respiratory syndrome patients].
    Fan BX; Liu YN; Xie LX; Tian Q; Chen LA; Chen WJ; Wen J
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1690-2. PubMed ID: 15569426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Consecutive five-year follow-up analysis of specific IgG antibody of 22 cases of SARS patients after recovery].
    Wang HJ; Zhang LL; Tan WJ; Zhou WM; Yan WZ; Peng K; Ruan L
    Bing Du Xue Bao; 2010 Jul; 26(4):295-7. PubMed ID: 20836383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Sero-epidemiological characteristics of antibody to SARS-associated coronavirus in Gansu Province].
    Yu DS; Fu SH; Meng L; Jiang JX; Wang BT; Wang J; Wang LH; He Y; Liang GD
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):325-7. PubMed ID: 15650780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies on IgG antibodies of SARS patients].
    Ou WN; Xie Y; Ling W; Li P; Feng L; Xu DZ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Mar; 18(1):51-3. PubMed ID: 15340527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seroepidemiological Study on SARS-CoV IgG Antibodies of Different Populations from Several Areas.
    Shi YL; Li LH; Chu XW; Chen Q; Wang YL; Ma QJ; Cao C; Yu SY
    Int J Biomed Sci; 2005 Jun; 1(1):72-5. PubMed ID: 23674957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019.
    Zhao J; Yuan Q; Wang H; Liu W; Liao X; Su Y; Wang X; Yuan J; Li T; Li J; Qian S; Hong C; Wang F; Liu Y; Wang Z; He Q; Li Z; He B; Zhang T; Fu Y; Ge S; Liu L; Zhang J; Xia N; Zhang Z
    Clin Infect Dis; 2020 Nov; 71(16):2027-2034. PubMed ID: 32221519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal profiles of immunoglobulin G antibodies against severe acute respiratory syndrome coronavirus components and neutralizing activities in recovered patients.
    Liu L; Xie J; Sun J; Han Y; Zhang C; Fan H; Liu Z; Qiu Z; He Y; Li T
    Scand J Infect Dis; 2011 Jul; 43(6-7):515-21. PubMed ID: 21366405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Convergent antibody responses to SARS-CoV-2 in convalescent individuals.
    Robbiani DF; Gaebler C; Muecksch F; Lorenzi JCC; Wang Z; Cho A; Agudelo M; Barnes CO; Gazumyan A; Finkin S; Hägglöf T; Oliveira TY; Viant C; Hurley A; Hoffmann HH; Millard KG; Kost RG; Cipolla M; Gordon K; Bianchini F; Chen ST; Ramos V; Patel R; Dizon J; Shimeliovich I; Mendoza P; Hartweger H; Nogueira L; Pack M; Horowitz J; Schmidt F; Weisblum Y; Michailidis E; Ashbrook AW; Waltari E; Pak JE; Huey-Tubman KE; Koranda N; Hoffman PR; West AP; Rice CM; Hatziioannou T; Bjorkman PJ; Bieniasz PD; Caskey M; Nussenzweig MC
    Nature; 2020 Aug; 584(7821):437-442. PubMed ID: 32555388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.
    Grifoni A; Weiskopf D; Ramirez SI; Mateus J; Dan JM; Moderbacher CR; Rawlings SA; Sutherland A; Premkumar L; Jadi RS; Marrama D; de Silva AM; Frazier A; Carlin AF; Greenbaum JA; Peters B; Krammer F; Smith DM; Crotty S; Sette A
    Cell; 2020 Jun; 181(7):1489-1501.e15. PubMed ID: 32473127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The time course of the immune response to experimental coronavirus infection of man.
    Callow KA; Parry HF; Sergeant M; Tyrrell DA
    Epidemiol Infect; 1990 Oct; 105(2):435-46. PubMed ID: 2170159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.